Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POISE-3
NL-OMON48217Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in perioperative bleeding (4 arms), sponsored by Population Health Research Institute. Primary endpoints: Co-primary efficacy outcome for TXA trial, Co-primary safety outcome for TXA trial and 1 more. Started Nov 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
perioperative bleeding
Beyond the preview
Go deeper on NL-OMON48217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48217.